| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |